PERSPECTIVE THERAPEUTICS INC (CATX)
US46489V3024 - Common Stock
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 10.05M 3.82% | 10.8M 7.46% | 1.434M -86.72% | 1.207M -15.83% | 693.151K -42.57% | 688.5K -0.67% | 14.679M 2,032.03% | 57.265M 290.12% | 188.27M 228.77% | 325.49M 72.88% | 590.07M 81.29% | |
| EBITDA YoY % growth | -3.25M 1.22% | -7.1M -118.46% | -39.955M -462.75% | -61.44M -53.77% | -88.352M -43.80% | -143.8M -62.76% | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -3.44M 1.15% | -7.39M -114.83% | -40.941M -454.01% | -67.775M -65.54% | -96.937M -43.03% | -121.226M -25.06% | -127.497M -5.17% | -89.318M 29.94% | 20.918M 123.42% | 135.36M 547.10% | 330.81M 144.39% | |
| Operating Margin | -34.23% | -68.43% | -2,855.02% | -5,615.16% | -13,984.95% | -17,607.23% | -868.57% | -155.97% | 11.11% | 41.59% | 56.06% | |
| EPS YoY % growth | -0.04 20.00% | -0.05 -25.00% | N/A -2,619.93% | -0.86 36.58% | -1.11 -28.24% | -1.21 -9.60% | -1.96 -61.54% | N/A | N/A | N/A | N/A |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.27 69.63% | -0.30 -49.18% | -0.33 -83.46% | -0.36 -70.00% | -0.39 -44.08% | -0.31 -2.56% | -0.31 7.34% | -0.32 11.43% | -0.33 15.23% |
| Revenue Q2Q % growth | 305.592K -84.98% | 205.02K -36.92% | 150.45K -71.40% | 153K -58.54% | 153K -49.93% | -100.00% | -100.00% | -100.00% | -100.00% |
| EBITDA Q2Q % growth | -18.62M 53.40% | -21.583M -70.63% | -24.011M -80.06% | -26.816M -81.94% | -30.07M -61.49% | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -21.17M 48.29% | -21.305M -63.82% | -22.515M -57.85% | -23.69M -40.66% | -25.093M -18.53% | -22.44M -5.33% | -22.44M 0.33% | -22.695M 4.20% | -23.205M 7.53% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | -0.21 47.50% | -0.22 | 0.01 | 3.49% |
| Q2 2024 Q2Q % growth | -0.18 -800.00% | -0.21 | 0.03 | 15.97% |
| Q1 2024 Q2Q % growth | -0.20 | -0.24 | 0.04 | 15.95% |
| Q4 2023 Q2Q % growth | -0.88 -8,700.00% | -0.37 | -0.51 | -135.27% |
| Q3 2023 Q2Q % growth | -0.40 -3,900.00% | -0.41 | 0.01 | 1.96% |
| Q2 2023 Q2Q % growth | -0.02 -100.00% | -0.01 | -0.01 | -96.08% |
| Q4 2022 Q2Q % growth | -0.01 | -0.01 | 0.00 | 1.96% |
| Q3 2022 Q2Q % growth | -0.01 | -0.01 | 0.00 | -30.72% |
| Q2 2022 Q2Q % growth | -0.01 | -0.01 | 0.00 | -30.72% |
| Q1 2022 Q2Q % growth | -0.02 -100.00% | -0.01 | -0.01 | -96.08% |
| Q4 2021 Q2Q % growth | -0.01 50.00% | -0.01 | 0.00 | 1.96% |
| Q3 2021 Q2Q % growth | -0.01 | -0.01 | 0.00 | 1.96% |
| Q2 2021 Q2Q % growth | -0.01 | -0.01 | 0.00 | 1.96% |
| Q1 2021 Q2Q % growth | -0.01 | -0.01 | 0.00 | 1.96% |
| Q4 2020 Q2Q % growth | -0.02 | -0.02 | 0.00 | -30.72% |
| Q3 2020 Q2Q % growth | -0.01 50.00% | -0.01 | 0.00 | 26.45% |
| Q2 2020 Q2Q % growth | -0.01 50.00% | -0.01 | 0.00 | 26.45% |
| Q1 2020 Q2Q % growth | -0.01 50.00% | -0.02 | 0.01 | 50.98% |
| Q4 2019 Q2Q % growth | -0.02 50.00% | -0.02 | 0.00 | 1.96% |
| Q3 2019 Q2Q % growth | -0.02 | -0.02 | 0.00 | 1.96% |
| Q2 2019 Q2Q % growth | -0.02 33.33% | -0.02 | 0.00 | 1.96% |
| Q1 2019 Q2Q % growth | -0.02 33.33% | -0.02 | 0.00 | 1.96% |
| Q4 2018 Q2Q % growth | -0.04 | -0.03 | -0.01 | -17.66% |
| Q3 2018 Q2Q % growth | -0.02 | -0.03 | 0.01 | 21.57% |
| Q2 2018 Q2Q % growth | -0.03 | -0.02 | -0.01 | -47.06% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 369K -83.11% | 269.392K | 99.608K | 36.98% |
| Q2 2024 Q2Q % growth | 526K -74.83% | 161.843K | 364.157K | 225.01% |
| Q1 2024 Q2Q % growth | 325K -84.22% | 325K | % | |
| Q4 2023 Q2Q % growth | 2.034M 10.54% | 1.953M | 81K | 4.15% |
| Q3 2023 Q2Q % growth | 2.185M 27.03% | 2.244M | -59K | -2.63% |
| Q2 2023 Q2Q % growth | 2.09M -16.73% | % | ||
| Q1 2023 Q2Q % growth | 2.06M -29.21% | % | ||
| Q4 2022 Q2Q % growth | 1.84M -34.75% | 2.901M | -1.061M | -36.57% |
| Q3 2022 Q2Q % growth | 1.72M -32.81% | 3.175M | -1.455M | -45.83% |
| Q2 2022 Q2Q % growth | 2.51M -7.38% | 3.008M | -498K | -16.56% |
| Q1 2022 Q2Q % growth | 2.91M 11.92% | 2.535M | 375K | 14.79% |
| Q4 2021 Q2Q % growth | 2.82M 19.49% | 2.754M | 66K | 2.40% |
| Q3 2021 Q2Q % growth | 2.56M 7.56% | 2.475M | 85K | 3.43% |
| Q2 2021 Q2Q % growth | 2.71M 18.86% | 2.433M | 277K | 11.39% |
| Q1 2021 Q2Q % growth | 2.6M -9.72% | 2.911M | -311K | -10.68% |
| Q4 2020 Q2Q % growth | 2.36M 6.79% | 2.754M | -394K | -14.31% |
| Q3 2020 Q2Q % growth | 2.38M 2.59% | 2.605M | -225K | -8.64% |
| Q2 2020 Q2Q % growth | 2.28M 18.75% | 2.352M | -72K | -3.06% |
| Q1 2020 Q2Q % growth | 2.88M 50.00% | 1.989M | 891K | 44.80% |
| Q4 2019 Q2Q % growth | 2.21M 16.32% | 2.059M | 151K | 7.33% |
| Q3 2019 Q2Q % growth | 2.32M 48.72% | 1.895M | 425K | 22.43% |
| Q2 2019 Q2Q % growth | 1.92M 20.00% | 1.763M | 157K | 8.91% |
| Q1 2019 Q2Q % growth | 1.92M 22.29% | 1.833M | 87K | 4.75% |
| Q4 2018 Q2Q % growth | 1.9M | 1.583M | 317K | 20.03% |
| Q3 2018 Q2Q % growth | 1.56M | 1.566M | -6K | -0.38% |
| Q2 2018 Q2Q % growth | 1.6M | 1.571M | 29K | 1.85% |
| Q1 2018 Q2Q % growth | 1.57M | 2.539M | -969K | -38.16% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 1.54% | 0% | 3.25% |
| Revenue | 0% | 91.62% | 0% | -0.82% |